Ls Investment Advisors, LLC Regenxbio Inc. Transaction History

Ls Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$27.01 - $40.26 $65,796 - $98,073	-2,436 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$27.75 - $43.44 $2,997 - $4,691	108 Added 4.64%	2,436 $90,000
Q1 2019 Apr 25, 2019	BUY	$40.82 - $62.45 $2,775 - $4,246	68 Added 3.01%	2,328 $133,000
Q4 2018 Feb 01, 2019	BUY	$39.11 - $75.15 $34,182 - $65,681	874 Added 63.06%	2,260 $95,000
Q3 2018 Nov 13, 2018	BUY	$65.0 - $82.15 $8,710 - $11,008	134 Added 10.7%	1,386 $105,000
Q2 2018 Jul 20, 2018	BUY	$27.2 - $74.35 $34,054 - $93,086	1,252 New	1,252 $90,000

197

43.2M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $433M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ls Investment Advisors, LLC with notifications on news.